Seizure course of PCDH19 clustering epilepsy in female children: A multicentre cohort study in China

被引:1
|
作者
Chen, Yi [1 ]
Liu, Aijie [2 ]
Zhang, Xiaoli [3 ]
Ma, Xiuwei [4 ]
Sun, Dan [5 ]
Tian, Xiaojuan [6 ]
Wu, Wenjuan [7 ]
Zeng, Qi [8 ]
Jiang, Yuwu [1 ]
Zhang, Yuehua [1 ,9 ]
机构
[1] Peking Univ, Hosp 1, Dept Pediat, Beijing, Peoples R China
[2] Capital Inst Pediat, Dept Pediat Neurol, Beijing, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 3, Dept Pediat, Zhengzhou, Peoples R China
[4] Gen Mil Hosp Beijing, Bayi Childrens Hosp, Dept Neurol, Beijing, Peoples R China
[5] Wuhan Childrens Hosp, Dept Neurol, Wuhan, Peoples R China
[6] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Neurol, Beijing, Peoples R China
[7] Childrens Hosp Hebei Prov, Dept Neurol, Shijiazhuang, Peoples R China
[8] Shenzhen Childrens Hosp, Dept Neurol, Shenzhen, Peoples R China
[9] Peking Univ, Dept Pediat, Hosp 1, Beijing 100034, Peoples R China
来源
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY | 2024年 / 66卷 / 06期
关键词
ANTISEIZURE MEDICATION WITHDRAWAL; X-LINKED INHERITANCE; PCDH19-RELATED EPILEPSY; ANTIEPILEPTIC DRUGS; MUTATIONS; OUTCOMES;
D O I
10.1111/dmcn.15803
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim: To investigate the seizure course of PCDH19 clustering epilepsy (PCDH19-CE) in a cohort of female children in China.Method: This ambidirectional cohort study examined 113 female patients with PCDH19-CE through multicentre collaboration. Prognostic factors for seizure freedom were evaluated by multivariate Cox regression analysis.Results: The median seizure course period from seizure onset was 6 years 6 months. Of 113 patients, 78% and 56% experienced seizure freedom for at least 1 year and at least 2 years respectively. In patients younger than 5 years (n = 30), 5 to 10 years (n = 52), and older than 10 years (n = 31), 57%, 81%, and 94% experienced at least 1 year of seizure freedom, and 32%, 52%, and 84% experienced at least 2 years of seizure freedom, respectively. However, 58% (65 out of 113) relapsed at least once after more than 1 year of seizure freedom without trigger exposure (40%) or because of common triggers, including fever (43%) and antiseizure medication (ASM) reduction (29%). There was an 84% risk of seizure relapse after ASM reduction attempts. The likelihood of seizure freedom decreased with early age at seizure onset and developmental delay.Interpretation: Patients with PCDH19-CE exhibit increasing seizure freedom with age, but there is a risk of relapse. ASM reduction in children younger than 10 years old requires caution. Patients with early seizure onset and developmental delay have a reduced chance of seizure freedom.
引用
收藏
页码:804 / 815
页数:12
相关论文
共 50 条
  • [21] NGS-Based Identification of Two Novel PCDH19 Mutations in Female Patients with Early-Onset Epilepsy
    Szalai, Renata
    Hadzsiev, Kinga
    Till, Agnes
    Fogarasi, Andras
    Bodo, Timea
    Buki, Gergely
    Banfai, Zsolt
    Bene, Judit
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [22] Novel De Novo PCDH19 Mutations in Three Unrelated Females With Epilepsy Female Restricted Mental Retardation Syndrome
    Jamal, Seema M.
    Basran, Raveen K.
    Newton, Stephanie
    Wang, Zhenyuan
    Milunsky, Jeff M.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2010, 152A (10) : 2475 - 2481
  • [23] Antiseizure medication withdrawal in seizure-free patients with PCDH19-related epilepsy: A multinational cohort survey
    Aledo-Serrano, Angel
    del Ser, Teodoro
    Gil-Nagel, Antonio
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2020, 80 : 259 - 261
  • [24] The female epilepsy protein PCDH19 is a new GABAAR-binding partner that regulates GABAergic transmission as well as migration and morphological maturation of hippocampal neurons
    Bassani, Silvia
    Cwetsch, Andrzej W.
    Gerosa, Laura
    Serratto, Giulia M.
    Folci, Alessandra
    Hall, Ignacio F.
    Mazzanti, Michele
    Cancedda, Laura
    Passafaro, Maria
    HUMAN MOLECULAR GENETICS, 2018, 27 (06) : 1027 - 1038
  • [25] Multicenter retrospective study of patients with PCDH19-related epilepsy: The first Hungarian cohort
    Kovacs, Monika
    Fogarasi, Andras
    Hegyi, Marta
    Siegler, Zsuzsanna
    Kelemen, Anna
    Mellar, Monika
    Orbok, Anna
    Simon, Gabor
    Farkas, Kristof
    Bessenyei, Monika
    Hollody, Katalin
    EPILEPTIC DISORDERS, 2024, 26 (05) : 685 - 693
  • [26] Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy
    Sullivan, Joseph
    Gunning, Boudewijn
    Zafar, Muhammad
    Guerrini, Renzo
    Gecz, Jozef
    Kolc, Kristy L.
    Zhao, Yufan
    Gasior, Maciej
    Aimetti, Alex A.
    Samanta, Debopam
    EPILEPSY RESEARCH, 2023, 191
  • [27] Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy
    Sullivan, J.
    Gunning, B.
    Zafar, M.
    Guerrini, R.
    Zolnowska, M.
    Gecz, J.
    Samanta, D.
    EPILEPSIA, 2022, 63 : 239 - 240
  • [28] COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study
    Goetzinger, Florian
    Santiago-Garcia, Begona
    Noguera-Julian, Antoni
    Lanaspa, Miguel
    Lancella, Laura
    Carducci, Francesca I. Calo
    Gabrovska, Natalia
    Velizarova, Svetlana
    Prunk, Petra
    Osterman, Veronika
    Krivec, Uros
    Lo Vecchio, Andrea
    Shingadia, Delane
    Soriano-Arandes, Antoni
    Melendo, Susana
    Lanari, Marcello
    Pierantoni, Luca
    Wagner, Noemie
    L'Huillier, Arnaud G.
    Heininger, Ulrich
    Ritz, Nicole
    Bandi, Srini
    Krajcar, Nina
    Roglic, Srdan
    Santos, Mar
    Christiaens, Christelle
    Creuven, Marine
    Buonsenso, Danilo
    Welch, Steven B.
    Bogyi, Matthias
    Brinkmann, Folke
    Tebruegge, Marc
    LANCET CHILD & ADOLESCENT HEALTH, 2020, 4 (09): : 653 - 661
  • [29] Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study
    Lamberink, Herm J.
    Otte, Willem M.
    Bluemcke, Ingmar
    Braun, Kees P. J.
    LANCET NEUROLOGY, 2020, 19 (09): : 748 - 757
  • [30] Characteristics and course of idiopathic hypertrophic cardiomyopathy in children. A multicentre cohort study of Italian patients
    Biagini, E.
    Limongelli, G.
    Autore, C.
    Spirito, P.
    Pacileo, G.
    Egidy, G.
    Formisano, F.
    Picchio, F. M.
    Calabro', R.
    Rapezzi, C.
    Limongelli, G.
    EUROPEAN HEART JOURNAL, 2008, 29 : 58 - 58